Cite Filings / MIRM / 0001950047-26-007935
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Mirum Pharmaceuticals, Inc. · Filed 2026-08-11 · Acc 0001950047-26-007935

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-08-18 144 Sale of Securities
  • 2026-08-13 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-08-12 4 CHIEF FINANCIAL OFFICER sold 6,001 shares at $99.90 ($599,510)
  • 2026-08-11 144 Sale of Securities
  • 2026-08-11 4 CHIEF EXECUTIVE OFFICER sold 20,000 shares at an average $98.92 ($1,978,402)
  • 2026-08-10 144 Sale of Securities
  • 2026-08-06 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…